BCL11B anticorps (Internal Region)

N° du produit ABIN6258605

Détail du produit anti-BCL11B anticorps

Antigène: BCL11B (B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B))

Épitope: Internal Region

Reactivité: Humain, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL11B est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF)

Specificité: BCL11B Antibody detects endogenous levels of total BCL11B.

Homologie: Pig,Bovine,Sheep,Dog,Chicken,Xenopus

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human BCL11B, corresponding to a region within the internal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Date de péremption: 12 months

Détails sur BCL11B

Antigène: BCL11B (B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B))

Autre désignation: BCL11B (BCL11B Produits)

Synonymes: anticorps BCL11B, anticorps 9130430L19Rik, anticorps AI604821, anticorps B630002E05Rik, anticorps BCL-11B, anticorps Ctip2, anticorps Rit1, anticorps ATL1, anticorps ATL1-alpha, anticorps ATL1-beta, anticorps ATL1-delta, anticorps ATL1-gamma, anticorps CTIP-2, anticorps CTIP2, anticorps RIT1, anticorps ZNF856B, anticorps hRIT1-alpha, anticorps B-cell CLL/lymphoma 11B, anticorps B cell leukemia/lymphoma 11B, anticorps B-cell CLL/lymphoma 11B (zinc finger protein), anticorps BCL11B, anticorps Bcl11b

Sujet:

Description: Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus (PubMed:27959755). Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4+ T-lymphocytes (PubMed:16809611). Tumor-suppressor that represses transcription through direct, TFCOUP2-independent binding to a GC-rich response element (By similarity). May also function in the P53-signaling pathway (By similarity).

Gene: BCL11B

Poids moléculaire: ?95 kDa

ID gène: 64919

UniProt: Q9C0K0